Trinity Biotech (TRIB) Net Margin (2016 - 2024)
Historic Net Margin for Trinity Biotech (TRIB) over the last 16 years, with Q4 2024 value amounting to 102.06%.
- Trinity Biotech's Net Margin fell 610400.0% to 102.06% in Q4 2024 from the same period last year, while for Jun 2025 it was 1355.08%, marking a year-over-year increase of 13930900.0%. This contributed to the annual value of 51.66% for FY2024, which is 94000.0% down from last year.
- Latest data reveals that Trinity Biotech reported Net Margin of 102.06% as of Q4 2024, which was down 610400.0% from 31.87% recorded in Q3 2024.
- Trinity Biotech's 5-year Net Margin high stood at 33.39% for Q3 2020, and its period low was 133.93% during Q2 2023.
- In the last 5 years, Trinity Biotech's Net Margin had a median value of 36.44% in 2023 and averaged 32.42%.
- Its Net Margin has fluctuated over the past 5 years, first plummeted by -1024600bps in 2022, then soared by 904500bps in 2024.
- Quarter analysis of 5 years shows Trinity Biotech's Net Margin stood at 29.17% in 2020, then tumbled by -162bps to 17.99% in 2021, then tumbled by -282bps to 68.68% in 2022, then skyrocketed by 40bps to 41.02% in 2023, then plummeted by -149bps to 102.06% in 2024.
- Its Net Margin was 102.06% in Q4 2024, compared to 31.87% in Q3 2024 and 43.48% in Q2 2024.